VICAR: Comparison of Two Surgical Sequences "Cataract Surgery Then Vitrectomy" Versus "Vitrectomy Then Cataract Surgery" Under Local-regional Anesthesia

Sponsor
Elsan (Other)
Overall Status
Recruiting
CT.gov ID
NCT05583331
Collaborator
(none)
60
1
2
31.9
1.9

Study Details

Study Description

Brief Summary

Cataracts and vitreo-retinal conditions are frequently associated and can lead to a combined surgery to treat both diseases at the same time. To date, in most cases cataract surgery is usually performed first, then followed by vitrectomy. However, there isn't any standard guidelines indicating what would be the best chronological order, or sequence, when performing those procedures. This randomised, double-arm, open-label study aims at investigating whether the sequence "cataract surgery then vitrectomy" or "vitrectomy then cataract surgery" can have an impact on iris hernia occurence.

Condition or Disease Intervention/Treatment Phase
  • Procedure: Cataract surgery
  • Procedure: Vitrectomy
N/A

Detailed Description

Cataracts and vitreo-retinal conditions are frequently associated, such as epimacular membranes, vitreomacular tractions, macular holes, or even macular edema. Cataract is also a frequent complication of posterior vitrectomy. Surgical treatment for pre- or post-vitrectomy cataract is corneal phacoemulsification with intraocular lens implantation.

Many patients undergoing vitrectomy alone consult five to ten years later, without useful vision due to a dense cataract that might be more complicated to treat at a late stage. Indeed, if the phacoemulsification on a previously vitrectomized eye is not an issue in the first years, the intervention can be complicated ten years later, due to nuclear hardness and zonular weakness.

To date, there are no recommendations regarding the surgical sequence for the combination of cataract surgery and vitrectomy. The most-used sequence is to start with cataract surgery and then to perform the vitrectomy most often in 25 gauges (retinal surgery). When we start with cataract surgery under locoregional anesthesia, we often have (in about 15% of cases) iris hernia, which causes intraoperative discomfort (need to put stitches on the cornea), intraoperative miosis, pigments release, which can interfere with visualization during vitrectomy and which require dilating agents use.

The hypothesis of this study is that reversing the order of interventions and starting with vitrectomy could in particular reduce the incidence of intraoperative and postoperative complications.

Study Design

Study Type:
Interventional
Anticipated Enrollment :
60 participants
Allocation:
Randomized
Intervention Model:
Parallel Assignment
Intervention Model Description:
A prospective, randomised, double-arms, parallel, open-label study.A prospective, randomised, double-arms, parallel, open-label study.
Masking:
None (Open Label)
Primary Purpose:
Treatment
Official Title:
Comparison of Two Surgical Sequences "Cataract Surgery Then Vitrectomy" Versus "Vitrectomy Then Cataract Surgery" Under Local-regional Anesthesia. A Pilot, Exploratory, Monocentric, Prospective, Randomized Study
Actual Study Start Date :
Jan 3, 2023
Anticipated Primary Completion Date :
Jan 1, 2024
Anticipated Study Completion Date :
Sep 1, 2025

Arms and Interventions

Arm Intervention/Treatment
Active Comparator: Cataract surgery then Vitrectomy

Patients will undergo first the cataract surgery then the vitrectomy, as a combined surgery performed on the same day.

Procedure: Cataract surgery
Cataract surgery will be performed as per local practice and standard guidelines.

Procedure: Vitrectomy
Vitrectomy will be performed as per local practice and standard guidelines.

Experimental: Vitrectomy then cataract surgery

Patients will undergo first the vitrectomy then the cataract surgery, as a combined surgery performed on the same day.

Procedure: Cataract surgery
Cataract surgery will be performed as per local practice and standard guidelines.

Procedure: Vitrectomy
Vitrectomy will be performed as per local practice and standard guidelines.

Outcome Measures

Primary Outcome Measures

  1. Intraoperative iris hernia occurence [During the combined surgery]

Secondary Outcome Measures

  1. Other intraoperative complications occurence [During the combined surgery]

  2. Post-operative complications occurence [At 6 months after the combined surgery]

  3. Combined surgery duration in minutes [At the end of the combined surgery]

  4. Ocular hypertension occurence [At 1 month, 3 months and 6 months after combined surgery]

  5. Combined Surgery-related costs assessment [At the time of the combined surgery.]

  6. Visual acuity assessment [At 6 months after combined surgery.]

Eligibility Criteria

Criteria

Ages Eligible for Study:
18 Years and Older
Sexes Eligible for Study:
All
Accepts Healthy Volunteers:
No
Inclusion Criteria:
  • Man or woman aged 18 years old or more

  • Patient with macular disease requiring vitrectomy

  • Patient with cataract requiring surgery

  • Patient suitable for local-regional anesthesia

  • Patient suitable for undergoing both surgical procedures consecutively and in any order

  • Patient that have given informed consent before performing any study-related procedure

  • Patient affiliated to a social security scheme

Exclusion Criteria:
  • Pseudophakic patients

  • Contra-indications to local-regional anesthesia

  • Pregnant or breastfeeding patients

  • Patients under legal protection

Contacts and Locations

Locations

Site City State Country Postal Code
1 Institut Ophtalmique de Somain Somain France 59490

Sponsors and Collaborators

  • Elsan

Investigators

None specified.

Study Documents (Full-Text)

None provided.

More Information

Publications

None provided.
Responsible Party:
Elsan
ClinicalTrials.gov Identifier:
NCT05583331
Other Study ID Numbers:
  • VICAR
  • 2022-A00886-37
First Posted:
Oct 17, 2022
Last Update Posted:
Jan 13, 2023
Last Verified:
Jan 1, 2023
Individual Participant Data (IPD) Sharing Statement:
No
Plan to Share IPD:
No
Studies a U.S. FDA-regulated Drug Product:
No
Studies a U.S. FDA-regulated Device Product:
No
Additional relevant MeSH terms:

Study Results

No Results Posted as of Jan 13, 2023